Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-18 @ 3:45 PM
Study NCT ID:
NCT05940532
Status:
RECRUITING
Last Update Posted:
2023-07-11
First Post:
2023-06-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
Sponsor:
Hunan Cancer Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Carcinoma, Non-Small-Cell Lung | View |